NLNatalie A. Lowenstein

Natalie A. Lowenstein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Natalie A. Lowenstein has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Surgical Risk and Patient-Reported Outcomes in 3- and 4-Level Anterior Cervical Discectomy and Fusion: A Comparative Study

    by Yulia Lee, Jonathan Dalton, Joydeep Baidya, Chloe Herczeg, Mitchell Ng, Alec Giakas, Jarod Olson, Robert J. Oris, Rachel Huang, Joshua Mathew, et al.

    Introduction: The existing literature on anterior cervical diskectomy and fusion (ACDF) predominantly focuses on 1- and 2-level procedures, leaving limited data comparing outcomes of 3- versus 4-level standalone ACDFs. Thus, the aim of this study was to compare surgical outcomes and patient-reported outcome measures (PROMs) of 3- versus 4-level ACDF. Methods: Patients who underwent 3- or 4-level ACDF within a single academic health system (2014 to 2020) were retrospectively identified. Surgical outcomes and PROMs were evaluated, including the 0 to 10 numeric rating scale for neck and arm pain, Short Form-12, Modified Japanese Orthopaedic Association (mJOA), and Neck Disability Index (NDI). Patients were excluded if they did not have complete preoperative or 1-year postoperative mJOA scores, underwent ACDF for tumor/trauma/infection, or had concomitant posterior cervical fusion. Results: A total of 256 patients were included (46 4-level ACDFs). Patients undergoing 4-level ACDF had higher BMI (30.8 vs. 28.9; P = 0.032) and a greater prevalence of myelopathy (45.7% vs. 33.3%; P = 0.018) but were otherwise demographically similar to 3-level ACDF patients. Four-level ACDF patients had a higher dysphagia rate (20% vs. 8.6%; P = 0.033) and a higher 30-day ED visit rate (6.5% vs. 0%; P = 0.005) but similar readmission rates and all other surgical outcomes. Patients with 4-level ACDF had better 6-month NDI scores but worse 1-year mJOA scores. All other PROM comparisons and deltas were similar at all time points. Conclusion: Patients undergoing 4-level ACDF had higher BMI and a greater prevalence of myelopathy than those undergoing 3-level ACDF; 4-level ACDF was associated with a higher rate of dysphagia and early postoperative ED utilization, but not readmissions. The groups otherwise did similarly with respect to surgical outcomes and PROM improvements. These findings suggest that extending fusion from three to four levels was not associated with increased surgical risk or inferior short-term functional or pain outcomes compared with 3-level ACDF.

  • Sports Medicine Patients Accurately Predict Their Pain Tolerance

    by Olivia L. Gordon, Natalie A. Lowenstein, Jillian L. Mazzocca, Jamie E. Collins, Giovanna Ignacio Subria Medina, Elizabeth G. Matzkin

    Introduction: The purpose of this study was to assess whether patients can accurately predict and perceive their pain using an objective test. The authors hypothesized that sports medicine patients would demonstrate the ability to predict their pain tolerance. Methods: Two hundred two patients receiving care from a single surgeon at an academic medical center consented to participate in this study. Exclusion criteria included non-English speaking subjects and those younger than 18 years. Subjects were administered a survey and a pain tolerance threshold test using the “OUCH Test” by a research assistant in an examination room during their clinical encounter. The “OUCH Test” is an instrument for predictive pain tolerance, with higher levels indicating higher pain tolerance. Results: One hundred ninety patients (94%) reached the highest level of the “OUCH Test.” One hundred sixteen patients (57%) reported that they had reached a higher level on the device than they initially predicted. The correlation between actual and predicted level reached on the “OUCH Test” device was significant (r = 0.344 confidence interval, 0.217–0.461; P < 0.001). No notable differences were observed in “OUCH Test” results when comparing male and female patients, smokers and nonsmokers, Worker's Compensation patients, or patients who used pain medication in the 24 hours before their clinic visit. Discussion: This study demonstrates that sports medicine patients can predict and perceive their pain tolerance with relative accuracy, offering a valuable tool for optimizing clinical decision making. Level of Evidence: II—Prospective Cohort Study.

  • Open Access

    The impact of operative level on reoperation rates and short-term patient-reported outcomes in 3-level anterior cervical discectomy and fusion

    by Yulia Lee, Chloe Herczeg, Mitchell K. Ng, Jonathan Dalton, Rachel Huang, Joydeep Baidya, Jarod Olson, Robert J. Oris, Rajkishen Narayanan, William Green, et al.

    Purpose: To examine whether clinical outcomes and patient-reported outcomes (PROMs) differ when patients are stratified by operative level in 3-level ACDF procedures. Methods: In this retrospective single-institution cohort study, patients undergoing 3-level ACDF (2014–2020) were reviewed for demographics, clinical outcomes, and PROMs. Patients with operative indications of infection/cancer/trauma/deformity were excluded. Patients with incomplete preoperative or 1-year postoperative PROMs were also excluded. PROMs, including SF-12, VAS Neck, VAS Arm, mJOA, and NDI, were assessed preoperatively and at 3, 6, and 12 months postoperatively. One-year MCID achievement was calculated using established thresholds. Patients were stratified and compared by construct level (C3-C6, C4-C7, and C5-T1). Results: Patients undergoing C3–C6 fusions were older than those in the C4–C7 group (62.7 versus 58.1 years, P = 0.007). The C5–T1 cohort had a higher 2-year reoperation rate compared to the C4–C7 cohort (18.2% versus 0.77%, P = 0.048). Baseline VAS Arm scores were worse in the C4–C7 group, with greater improvement at 1 year compared to the C3–C6 group (–3.45 versus − 2.27, P = 0.047). A transient difference in NDI at 3 months resolved by 6 months. MCID achievement rates across all PROMs did not differ significantly between groups. Conclusion: In patients undergoing 3-level ACDF, the operative level was associated with reoperation rates and baseline symptom profiles. However, the likelihood of achieving clinically meaningful improvements was similar across levels. Our findings support the need for construct-specific preoperative counseling while reinforcing the overall efficacy of 3-level ACDF across cervical levels.

  • Open Access

    Changes in mental health and joint-specific patient-reported outcome measures following arthroscopic shoulder labral repair

    by Kristen E. Hines, Natalie A. Lowenstein, Jillian L. Mazzocca, Cale A. Jacobs, Elizabeth G. Matzkin

  • Discrepancies in Periprosthetic Joint Infection Diagnostic Criteria Reporting and Use: A Scoping Review and Call for a Standard Reporting Framework

    by Alexandra L. Ba Hohmann, Cristian A. BS DeSimone, Natalie A. Lowenstein, Carl Deirmengian, Yale A. Fillingham

    Background: Numerous criterion-based definitions of periprosthetic joint infection (PJI) with differing criteria and point systems have been published, but the frequency of their use or application to study methods in publications on PJI has not been evaluated. Assessing the use of these definitions in studies is an important step to ensuring the validity and reproducibility of PJI research and to determining best practices for the application of these definitions in future research. Questions/purposes: As a scoping review, we identified and evaluated studies published since 2012 that defined PJI, and we asked: (1) Which of those definitions are cited most frequently in other peer-reviewed publications? (2) How often are the definition criteria and scoring systems reported in the methods beyond the name or citation or modified from the published definition? (3) How often did the PJI definition stated in a citing study’s methods section fail to align with the definition provided in the cited source? Methods: To identify published PJI definition citations, we queried PubMed for studies on PJI published between January 1, 2012, and August 1, 2023, identifying 75 unique citations in studies with human patients diagnosed with PJI. This study focused on PJI definitions detailing specific clinical and laboratory criteria for PJI, recognizing and including six formal definitions for PJI presented across 16 publications: the 2011 Musculoskeletal Infection Society (MSIS), 2013 MSIS/International Consensus Meeting (ICM), 2013 Infectious Disease Society of America (IDSA), 2018 ICM, and 2021 European Bone and Joint Infection Society (EBJIS) definitions, and an unendorsed 2018 Definition. Back citation of these 16 publications identified 457 studies (Journal of Arthroplasty n = 285, Clinical Orthopaedics and Related Research n = 69, Bone and Joint Journal n = 58, Journal of Bone and Joint Surgery n = 45) published between January 1, 2012, and December 31, 2022, that cited one of the identified PJI definition citations. Trends in PJI definition citation and reporting were assessed based on the following criteria: (1) the PJI definition claimed in the methods, (2) the cited reference to this claim, (3) the description of the definition in the manuscript, and (4) the definition modification. Results: Of 457 studies published between 2012 and 2022 that cited at least one PJI definition, the most cited was the 2011 MSIS definition (40% [183 studies]), followed by the 2013 MSIS/ICM definition (30% [139]), the unendorsed 2018 Definition (14% [65]), the 2018 ICM definition (3.7% [17]), the 2013 IDSA definition (3.5% [16]), and the 2021 EBJIS definition (one study); 7.9% (36) cited multiple definitions. Overall, 31% (141 of 457) of studies detailed the PJI definition beyond its name and citation. Authors modified definitions in 18% (83 of 457) of studies. Of the 98 studies using a definition with an inconclusive category, 18% (18 of 98) provided details on the inconclusive group. The PJI definition stated in the methods section did not align with the cited source in 19% (86 of 457) of studies. Of these, 85% (73 of 86) cited the unendorsed 2018 Definition while claiming use of an endorsed definition. Conclusion: The 2011/2013 MSIS definitions of PJI remain commonly cited through 2022 despite the availability of newer definitions. Many studies on PJI definitions suffer from a lack of methodological transparency, hindering both reproducibility and the assessment of their validity. There also exists an alarming rate of citation errors and widespread use of unendorsed scoring systems despite claims of adherence to accepted standards, representing a systematic error in the existing scientific record. Clinical Relevance: In response to these findings, we recommend that academic societies establish a standard reporting framework and checklist for studies using formal PJI definitions, such as those that exist for systematic reviews (Preferred Reporting Items for Systematic Reviews and Meta-Analyses [PRISMA]), randomized trials (Consolidated Standards of Reporting Trials [CONSORT]), and observational studies (Strengthening the Reporting of Observational Studies in Epidemiology [STROBE]). The MSIS and EBJIS, as discussed in an accompanying letter to the editor, are creating an endorsed standard reporting framework that aims to improve reporting transparency in the PJI research.


  • Open Access

    Resolution of Pain at Night and Improved Functional Outcomes After Arthroscopic Partial Meniscectomy

    by Evan T. Zheng, Koya Osada, Jillian L. Mazzocca, Natalie A. Lowenstein, Jamie E. Collins, Elizabeth G. Matzkin

    Background: Arthroscopic partial meniscectomy (APM) is performed for symptomatic meniscal tears that fail conservative treatment. Patients often report pain at night, although little research has been done to evaluate corresponding outcomes. Purpose: To (1) evaluate patients with and without preoperative nighttime pain who underwent APM and (2) assess postoperative resolution of symptoms and associated patient-reported outcome measures (PROMs). Study Design: Case series; Level of evidence, 4. Methods: Consecutive patients undergoing primary APM with or without chondroplasty at a tertiary academic center were prospectively enrolled in a database. Patient characteristics and PROMs were obtained pre- and postoperatively up to 2 years—including the visual analog pain scale, Knee injury and Osteoarthritis Outcome Score (KOOS), Marx Scale, and Veterans RAND 12-Item Health Survey (VR-12) physical and mental components. Patients were included if they had a minimum 3-month PROMs follow-up. Pain at night was defined as reporting greater than mild pain on KOOS P7. Intraoperatively, cartilage was assessed using the Outerbridge Classification. Results: A total of 587 patients were included, with 299 (50.9%) reporting preoperative pain at night, which corresponded with worse baseline PROMs. These patients were older and more likely to be women and smokers. No significant difference was observed in Outerbridge grade between patients with and without preoperative pain at night. Postoperatively, nighttime pain resolved by 2 years in 274 (91.6%) patients, 219 of whom (79.9%) reported improvement by 3 months. Patients whose pain at night persisted had a longer duration of symptoms preoperatively, higher body mass index, and a lack of baseline mechanical symptoms. PROMs significantly improved for patients with and without preoperative pain at night, although patients with baseline pain had worse scores compared with those without preoperative nighttime pain. Conclusion: Over half of patients undergoing APM reported preoperative pain at night, which was associated with worse baseline functional scores. Postoperatively, >90% of patients with baseline pain at night noted resolution of symptoms by 2 years, with nearly 80% showing improvement by 3 months. Functional scores improved after surgery for patients with and without initial pain at night, remaining lower for patients who had preoperative nighttime pain.


  • Open Access

    Evaluating Donor-Recipient Sex Mismatch in Anterior Cruciate Ligament Reconstruction With Allograft: Outcomes at 2 Years Postoperatively

    by Connor R. Crutchfield, Natalie A. Lowenstein, Chilan B.G. Leite, Christian Lattermann, Elizabeth G. Matzkin

    Background: Female patients tend to suffer a greater risk of reinjury and worse patient-reported outcome measures (PROMs) after anterior cruciate ligament reconstruction (ACLR) than male patients, regardless of the graft type used. Purpose/Hypothesis: This study explored the role of donor-recipient sex mismatching to help explain these sex-based disparities in outcomes after ACLR with an allograft. The hypothesis was that allograft donor-recipient sex mismatch would adversely affect surgical outcomes at a 2-year follow-up, with male-to-female graft donations yielding the lowest rates of success. Study Design: Cohort study; Level of evidence, 3. Methods: Patients who underwent primary ACLR with an allograft between 2012 and 2022 were eligible for recruitment. The following PROMs were collected from baseline through a 2-year follow-up: Knee injury and Osteoarthritis Outcome Score subscales, Marx activity rating scale, visual analog scale for pain, and Veterans RAND 12-Item Health Survey. Demographic and graft-specific variables were also collected. Sex- matched cases were compared with sex- mismatched cases and an identical subgroup analysis was performed for female patients only. Results: Of the 112 included patients (N = 70 women), 59 (52.7%) were sex mismatched. The mean patient age was 40.7 ± 10.9 years, and the mean body mass index was 26.8 ± 4.7 kg/m2. Most reconstructions (89.3%) used a semitendinosus tendon graft, with a mean implanted graft diameter of 9.7 ± 0.5 mm (quadrupled). Of the mismatched cases, 96.6% involved a male allograft donated to female recipients. Overall, the matched group demonstrated higher PROM scores across all time points compared with the mismatched group, although statistical significance was only reached for the Marx score at baseline ( P = .012) and 1 year postoperatively ( P = .022). In the female-only subgroup analysis, a larger graft diameter was measured in the mismatched cases (receiving male allografts) compared with the matched female cases (9.7 ± 0.6 vs 9.2 ± 0.4 mm, respectively; P = .002). Moreover, the mismatched cases tended to report better postoperative PROM scores, although this trend was not statistically significant. Conclusion: The study findings indicated that male donors provided larger allografts than female donors, and that donor-recipient allograft sex matching did not contribute significantly to ACLR outcomes. Other factors may be more important to outcomes in female patients.


  • Open Access

    Improved patient reported outcomes with knotless double-row rotator cuff repair with and without lateral row biceps tenodesis at 2- and 5-years

    by Giovanna Medina, Mathew Quattrocelli, Natalie Lowenstein, Jamie Collins, Elizabeth Matzkin


  • Derivation of a Clinical Prediction Rule for Predicting Outcome After Partial Meniscectomy of the Knee: Response

    by Jeffrey N. Katz, Yuchiao Chang, Natalie A. Lowenstein, Hanna Mass, Angela M. Mercurio, Chierika Ukogu, Elizabeth G. Matzkin

  • Preoperative Predictors of Arthroscopic Partial Meniscectomy Outcomes: The APM Index Score

    by Natalie A. Lowenstein, Yuchiao Chang, Hanna Mass, Angela M. Mercurio, Chierika Ukogu, Jeffrey N. Katz, Elizabeth G. Matzkin

    Background: Preoperative risk factors contributing to poor outcomes after arthroscopic partial meniscectomy (APM) have not yet been consolidated and codified into an index scoring system used to predict APM success. Purpose: To create an index score using available preoperative factors to predict the likelihood of favorable postoperative outcomes after APM. Study Design: Case-control study; Level of evidence, 3. Methods: A consecutive cohort of patients undergoing primary APM were enrolled in this study. Patients completed pre- and postoperative patient-reported outcome measure (PROM) questionnaires that included the Knee injury and Osteoarthritis Outcome Score (KOOS), visual analog scale (VAS) for pain, Veterans RAND 12-Item Health Survey (VR-12 Physical and Mental), and Marx Activity Rating Scale (MARS). Multivariable logistic regression models were performed to evaluate independent predictors of KOOS Pain, Symptoms, and Activities of Daily Living scores and achievement of the minimal clinically important difference (MCID) and substantial clinical benefit (SCB). The authors assigned points to each variable proportional to its odds ratio, rounded to the nearest integer, to generate the index score. Results: In total, 468 patients (mean age, 49 years [SD, 10.4 years; range, 19-81 years]) were included in this study. In the univariate analysis, shorter symptom duration, lower Kellgren-Lawrence (KL) grade, lower preoperative KOOS Pain value, and lower VR-12 Physical score were associated with a higher likelihood of clinical improvement at 1 year. In the multivariable model for clinical improvement with MCID, symptom duration (6 months), KL grade (grade 0: OR, 3.54 [95% CI, 1.66-7.54]; grade 1: OR, 3.04 [95% CI, 1.48-6.26]; grade 2: OR, 2.31 [95% CI, 1.02-5.27], compared with grade 3), and preoperative KOOS Pain value (score 60) were independent significant predictors for clinical improvement. The scoring algorithm demonstrated that a higher total score predicted a higher likelihood of achieving the MCID: 0 = 40%, 1 = 68%, 2 = 80%, 3 = 89%, and 4 = 96%. Conclusion: Using this model, the authors developed an index score that, using preoperative factors, can help identify which patients will achieve clinical improvement after APM. Longer symptom duration and higher KL grade were associated with a decreased likelihood of clinical improvement as measured by KOOS Pain at 1 year postoperatively.